Assessment of Post-COVID-19 Manifestations in covid 19 recovered Patients in Dedicated Covid Hospital in Metropolitan City: Cohort Study
DOI:
https://doi.org/10.37506/w1vbk137Keywords:
COVID-19, post-COVID syndrome, long COVID, persistent symptoms.Abstract
Introduction: This study aimed to assess and characterize post-COVID-19 manifestations in recovered patients. A mixed retrospective and prospective cohort study was conducted over 18 months at a dedicated COVID-19 hospital, involving 300 adult patients who had recovered from COVID-19.
Objectives: Primary Objectives: a) To study the manifestations (Health status) of covid-19 infection. b) To study the manifestations of post covid-19 infection. Secondary Objectives: a) To study the manifestation of post Covid-19 infection with comorbidity b) To study the exacerbation of co-morbidity in covid 19. C) To study the demographic profile of Covid-19 infected patient.
Methods: The study included adults ≥18 years who had recovered from COVID-19. A sample size of 300 was recruited using convenient sampling. Data was collected via questionnaires and analyzed using SPSS software.
Results: The mean age of participants was 51.71 ± 14.22 years, with 68% males. Post-COVID-19 manifestations were observed in 92.3% of participants. The most common symptoms were fatigue (59%), muscle pain (52.3%), cough (19.3%), respiratory distress (17.7%), and joint pain (13.7%). Neuropsychiatric sequelae included headache (4.3%) and sleep disturbance (3%). Cardiovascular symptoms like chest pain and palpitations were reported by 2.3% of participants. An increase in hypertension (21%) and diabetes (17.33%) prevalence was observed post-recovery.
Significant associations were found between post-COVID-19 syndrome and gender, socioeconomic status, and comorbidities. Cough during acute infection was statistically associated with developing post-COVID-19 syndrome.
Conclusion & Recommendations: Patient care should continue even after recovery from COVID-19 infection. Strengthening of post- COVID-19 clinics and sensitization of healthcare staff are needed for proper identification and management of post-COVID manifestations. Long-term monitoring of recovered patients is recommended for evaluation and treatment of persistent or new symptoms. Recommendations include - 1) Early implementation of integrated rehabilitation services through both in-person and remote delivery models; 2) Establishment of multidisciplinary teams including physiotherapists, occupational therapists, nurses, psychologists, speech therapists, physicians, and social workers 3) Condition-specific interventions including energy conservation techniques, pain management, cognitive rehabilitation, and psychological support, with careful consideration of post-exertional symptom exacerbation (PESE) before implementing exercise-based interventions.
Keywords: COVID-19, post-COVID syndrome, long COVID, persistent symptoms.
References
Goenka A, Liu L. Infectious diseases, human capital and economic growth. Econ Theory. 2020;70(1):1-47. doi:10.1007/s00199-020-01261-2.
Hua J, Shaw R. Corona Virus (COVID-19) “Infodemic” and emerging issues through a data lens: the case of China. Int J Environ Res Public Health. 2020;17(7):2309. doi:10.3390/ijerph17072309.
Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020;395(10223):470-3. doi:10.1016/S0140-6736(20)30185-9.
Nature. COVID-19: a new challenge for human beings. Cell Mol Immunol. 2021. doi:10.1038/s41423-020-0407-x.
Castagnoli R, Votto M, Licari A, Brambilla I, Bruno R, Perlini S, et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review. JAMA Pediatr. 2020;174(9):882-9. doi:10.1001/jamapediatrics.2020.1467.
Johansson N, Kalin M, Tiveljung-Lindell A, Giske CG, Hedlund J. Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness. J Clin Microbiol. 2017;55(6):1426-36. doi:10.1128/JCM.02363-15.
Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72,314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-42. doi:10.1001/jama.2020.2648.
CDC COVID-19 Response Team. Severe outcomes among patients with coronavirus disease 2019 (COVID-19)—United States, February 12–March 16, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(12):343-6. doi:10.15585/mmwr.mm6912e2.
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-9. doi:10.1001/jama.2020.1585.
Mez J, Daneshvar DH, Kiernan PT, Abdolmohammadi B, Alvarez VE, Huber BR, et al. Clinicopathological evaluation of chronic traumatic encephalopathy in players of American football. JAMA. 2017;318(4):360-70. doi:10.1001/jama.2017.8334.
Udugama B, Kadhiresan P, Kozlowski HN, Malekjahani A, Osborne M, Li VY, et al. Diagnosing COVID-19: the disease and tools for detection. ACS Nano. 2020;14(4):3822-35. doi:10.1021/acsnano.0c02624.
Li T, Lu H, Zhang W. Clinical observation and management of COVID-19 patients. Emerg Microbes Infect. 2020;9(1):687-90. doi:10.1080/22221751.2020.1741327.
Gao J, Tian Z, Yang X. Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends. 2020;14(1):72-3. doi:10.5582/bst.2020.01047.
Elfiky AA. Anti-HCV nucleotide inhibitors repurposing against COVID-19. Life Sci. 2020;248:117477. doi:10.1016/j.lfs.2020.117477.
Chen C, Zhang Y, Huang J, Yin P, Cheng Z, Wu J, et al. Favipiravir versus arbidol for COVID-19: a randomized clinical trial. J Infect. 2020;81(4):e21-3. doi:10.1016/j.jinf.2020.03.022.
Fadel R, Morrison AR, Vahia A, Smith ZR, Chaudhry Z, Bhargava P, et al. Early short-course corticosteroids in hospitalized patients with COVID-19. Clin Infect Dis. 2020;71(16):2114-20. doi:10.1093/cid/ciaa601.
Islam MF, Cotler J, Jason LA. Post-viral fatigue and COVID-19: lessons from past epidemics. Emerg Infect Dis. 2020;26(7):1673-80. doi:10.3201/eid2607.200829.
Moldofsky H, Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression, and disordered sleep in chronic post-SARS syndrome: a case-controlled study. BMC Neurol. 2011;11:37. doi:10.1186/1471-2377-11-37.
World Health Organization (WHO). Guidance on management of severe acute respiratory infection (SARI) when COVID-19 is suspected. Geneva: WHO; 2020. Available from: https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected.
Tenforde MW, Kim SS, Lindsell CJ, Billig Rose E, Shapiro NI, Files DC, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network—United States, March–June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(30):993-8. doi:10.15585/mmwr.mm6930e1.
Del Rio C, Collins LF, Malani P. Long-term health consequences of COVID-19. JAMA. 2020;324(17):1723-4. doi:10.1001/jama.2020.19719.
Institute of Medicine. Myalgic encephalomyelitis/chronic fatigue syndrome. Washington, DC: National Academies Press; 2015. Available from: http://www.iom.edu/MECFS.
Mahmud R, Rahman MM, Rassel MA, Monayem FB, Sayeed SKJB, Islam MS, et al. Post-COVID-19 syndrome among symptomatic COVID-19 patients: a prospective cohort study in a tertiary care center of Bangladesh. PLoS One. 2021;16(4):e0249644. doi:10.1371/journal.pone.02496443.
Majumder S. Socioeconomic status scales: revised Kuppuswamy, BG Prasad, and Udai Pareekh’s scale updated for 2021. J Fam Med Prim Care. 2021;10(11):3964-7. doi:10.4103/jfmpc.jfmpc_677_21.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Vinay Kumar, Vandana Kashyap, Kinjal Chauhan, Adsul BB, Smita Chavhan
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.